loadpatents
name:-0.025379180908203
name:-0.018380165100098
name:-0.0066680908203125
QI; Ning Patent Filings

QI; Ning

Patent Applications and Registrations

Patent applications and USPTO patent grants for QI; Ning.The latest application filed is for "temporary plugging agent and preparation method thereof, and method for temporary plugging and fracturing of high-temperature reservoir".

Company Profile
5.15.19
  • QI; Ning - Dongying City Shandong
  • Qi; Ning - Dongying CN
  • Qi; Ning - Beijing CN
  • Qi; Ning - Nantong CN
  • Qi; Ning - Somerset NJ
  • Qi; Ning - Rahway NJ
  • Qi; Ning - Avenal NJ
  • Qi; Ning - Hamden CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Temporary Plugging Agent And Preparation Method Thereof, And Method For Temporary Plugging And Fracturing Of High-temperature Reservoir
App 20220195284 - GUO; Tiankui ;   et al.
2022-06-23
Deep-sea submarine gas hydrate collecting method and production house
Grant 11,313,207 - Yang , et al. April 26, 2
2022-04-26
Deep-sea Submarine Gas Hydrate Collecting Method And Production House
App 20220098958 - YANG; Jinxiu ;   et al.
2022-03-31
Method for displaying current geographical location on emergency call screen and terminal
Grant 11,109,191 - Qi , et al. August 31, 2
2021-08-31
Silk fibroin-based optical anti-counterfeiting mark and preparation method thereof
Grant 10,857,830 - Zhang , et al. December 8, 2
2020-12-08
Silk Fibroin-based Optical Anti-counterfeiting Mark And Preparation Method Thereof
App 20200079133 - ZHANG; Keqin ;   et al.
2020-03-12
Antiviral oxime phosphoramide compounds
Grant 10,450,335 - Fu , et al. Oc
2019-10-22
Method For Displaying Current Geographical Location on Emergency Call Screen And Terminal
App 20190230476 - QI; Ning ;   et al.
2019-07-25
Antiviral Oxime Phosphoramide Compounds
App 20180362563 - Fu; Wenlang ;   et al.
2018-12-20
Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications
Grant 9,512,426 - Butora , et al. December 6, 2
2016-12-06
Method For Rapidly Evaluating Performance Of Short Interfering Rna With Novel Chemical Modifications
App 20150132761 - Butora; Gabor ;   et al.
2015-05-14
Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications
Grant 8,877,439 - Butora , et al. November 4, 2
2014-11-04
Method For Rapidly Evaluating Performance Of Short Interfering RNA With Novel Chemical Modifications
App 20120252027 - Butora; Gabor ;   et al.
2012-10-04
Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
Grant 8,138,336 - Magnuson , et al. March 20, 2
2012-03-20
Pyrrolotriazine Derivatives Useful For Treating Cancer Through Inhibition Of Aurora Kinase
App 20100273800 - Magnuson; Steven ;   et al.
2010-10-28
Heteroarylaminopyrazole Derivatives Useful For The Treatment Of Diabetes
App 20090209451 - Rudolph; Joachim ;   et al.
2009-08-20
Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
Grant 7,517,878 - Rudolph , et al. April 14, 2
2009-04-14
Anilinopyrazole derivatives useful for the treatment of diabetes
App 20080064734 - Rudolph; Joachim ;   et al.
2008-03-13
Anilinopyrazole derivatives useful for the treatment of diabetes
Grant 7,265,144 - Rudolph , et al. September 4, 2
2007-09-04
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders
Grant 7,109,196 - Wang , et al. September 19, 2
2006-09-19
1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders
App 20060189609 - Wang; Yamin ;   et al.
2006-08-24
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
App 20050215594 - O'Connor, Stephen J. ;   et al.
2005-09-29
Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
App 20050192294 - Rudolph, Joachim ;   et al.
2005-09-01
2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
Grant 6,919,371 - O'Connor , et al. July 19, 2
2005-07-19
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders
Grant 6,900,205 - Wang , et al. May 31, 2
2005-05-31
1,8 Naphthyridine derivatives and their use to treat diabetes and related disorders
App 20040209866 - Wang, Yamin ;   et al.
2004-10-21
Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-.gamma. binding agents
Grant 6,787,651 - Stolle , et al. September 7, 2
2004-09-07
Anilinopyrazole derivatives useful for the treatment of diabetes
App 20040157904 - Rudolph, Joachim ;   et al.
2004-08-12
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
App 20040072828 - O'Connor, Stephen J. ;   et al.
2004-04-15
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders
App 20040014751 - Wang, Yamin ;   et al.
2004-01-22
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
Grant 6,660,752 - O'Connor , et al. December 9, 2
2003-12-09
Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
App 20030087902 - Stolle, Andreas ;   et al.
2003-05-08
2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
App 20030078260 - O'Connor, Stephen J. ;   et al.
2003-04-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed